A double-blind placebo-controlled trial of L-threonine in amyotrophic lateral sclerosis.
J Neurol
; 239(2): 79-81, 1992 Feb.
Article
em En
| MEDLINE
| ID: mdl-1313078
ABSTRACT
Fifteen patients with the unequivocal diagnosis of amyotrophic lateral sclerosis (ALS) completed a 1-year randomized double-blind placebo-controlled trial of L-threonine (2 g daily). During the study, patients in the placebo group showed a decline in functional status consistent with the natural history of ALS, which was not statistically different from outcome in the patients in the L-threonine group.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Treonina
/
Esclerose Lateral Amiotrófica
Tipo de estudo:
Clinical_trials
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Neurol
Ano de publicação:
1992
Tipo de documento:
Article